China
· Delayed Price · Currency is CNY PharmaBlock Sciences (Nanjing) Company Description
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production.
It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and Full Time Equivalent (FTE).
The company also provides small molecule drug substance CDMO services, including optimal route scouting; FFS and FTE for process research and development of RSMs, intermediates, and APIs; impurity studies and synthesis; solid state chemistry; analytical development and quality control; cGMP manufacturing of intermediates and APIs; and CMC regulatory filing support.
In addition, it offers small molecule DP CDMO services, such as candidate screening and selection, early development, and full development; and new modality services, including target protein degrader, peptide, oligonucleotide, and ADC services.
The company was founded in 2006 and is based in Nanjing, the People's Republic of China.
| Country | China |
| Founded | 2006 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,455 |
| CEO | Minmin Yang |
Contact Details
Address: No. 81, Huasheng Road Nanjing, 210032 China | |
| Phone | 86 25 8691 8218 |
| Website | pharmablock.com |
Stock Details
| Ticker Symbol | 300725 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000035K5 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Dr. Minmin Yang Ph.D. | Co-Founder, Chairman and Chief Executive Officer |
| Wu Yifei | Secretary, Chief Financial Officer and Accounting Supervisor |
| Dr. Shijie Zhang Ph.D. | Chief Technology Officer |
| Dr. Jing Li Ph.D. | Senior Vice President of Process Chemistry and President of PharmaBlock (USA), Inc. |
| Dr. Shuhai Zhao Ph.D. | Co-founder and Chief Scientific Officer |
| Dr. David Chen Ph.D. | Executive Vice President, Chief Operation Officer and Head of CDMO |
| Dr. Dezhi Sha Ph.D. | Senior Vice President of Process Technology and Manufacturing |